Saturday 17 October 2026
Export CODX’s income statement to Excel — free account
Co-Diagnostics, Inc.
CODX Healthcare Medical Devices
Co-Diagnostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $622,500.00, down 84.1% from fiscal 2024. In the quarter to June 2026, revenue grew 1.96%, EPS grew 78.9% and free cash flow grew 17.5%, each against the same quarter a year earlier.
0.65
0.07
−9.72%
Follow CODX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 2 | 2 |
+8 more TTM periods Free account |
| (174.77%) | (151.66%) | (125.89%) | (62.12%) | ||
| (149.25%) | (126.56%) | (106.21%) | (54.95%) | ||
ROIC |
(337.68%) | (406.63%) | (358.57%) | (78.24%) | |
Return on Tangible Assets |
(1,093.26%) | (633.49%) | (377.40%) | (250.49%) | |
Average Days of Receivables |
26.56 | 41.88 | 137.73 | 703.63 | |
Free Cash Flow per Share |
(6.37) | (12.86) | (22.43) | (25.21) | |
Free Cash Flow |
(27.47) | (28.99) | (29.84) | (31.81) | |
Capital Expenditures |
(0.37) | (0.75) | (0.70) | (0.64) | |
| Other line items | |||||
Cash ROIC |
(167.89%) | (119.42%) | (91.77%) | (62.04%) | |
Accounts Receivable Turnover |
5.48 | 6.56 | 3.39 | 0.88 | |
Accounts Payable Turnover |
0.30 | 0.17 | 0.09 | 0.18 | |
Inventory Turnover |
0.42 | 0.41 | 0.22 | 0.28 | |
Average Days of Payables |
965.22 | 1,866.53 | 3,082.48 | 1,588.53 | |
Days of Inventory on Hand |
753.36 | 782.63 | 1,628.71 | 1,187.26 | |
Tax Rate |
(0.03) | (0.03) | (0.03) | (0.03) | |
Research and Development Expense of Revenue |
2,726.12% | 2,812.78% | 3,074.27% | 3,710.40% | |
Selling, General and Administrative Expense of Revenue |
1,349.90% | 1,528.88% | 1,837.67% | 3,083.70% | |
Share Based Compensation of Revenue |
169.88% | 240.46% | 382.83% | 671.29% | |
Operating CF/Net income |
0.58 | 0.58 | 0.62 | 0.97 | |
Depreciation/Fixed assets |
0.50 | 0.50 | 0.49 | 0.48 | |
Capex/Depreciation |
(0.37) | (0.69) | (0.63) | (0.54) | |
Revenue per Share |
0.17 | 0.32 | 0.47 | 0.40 | |
Operating CF per Share |
(6.29) | (12.53) | (21.90) | (24.70) | |
Capex per Share |
(0.09) | (0.33) | (0.53) | (0.51) | |
Capex to Sales |
0.51 | 1.04 | 1.12 | 1.26 |
Columns are period end dates